PL3897595T3 - Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną - Google Patents
Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularnąInfo
- Publication number
- PL3897595T3 PL3897595T3 PL19829158.5T PL19829158T PL3897595T3 PL 3897595 T3 PL3897595 T3 PL 3897595T3 PL 19829158 T PL19829158 T PL 19829158T PL 3897595 T3 PL3897595 T3 PL 3897595T3
- Authority
- PL
- Poland
- Prior art keywords
- ophthalmic
- treatment
- retinal disease
- nutraceutical composition
- neovascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306772 | 2018-12-20 | ||
| PCT/EP2019/086174 WO2020127641A1 (fr) | 2018-12-20 | 2019-12-19 | Composition ophtalmique nutraceutique pour le traitement de pathologies retiniennes a composante neovasculaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3897595T3 true PL3897595T3 (pl) | 2023-05-08 |
Family
ID=65200511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19829158.5T PL3897595T3 (pl) | 2018-12-20 | 2019-12-19 | Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240374634A1 (pl) |
| EP (1) | EP3897595B1 (pl) |
| CA (1) | CA3122227A1 (pl) |
| DK (1) | DK3897595T3 (pl) |
| ES (1) | ES2940767T3 (pl) |
| FI (1) | FI3897595T3 (pl) |
| HR (1) | HRP20230283T1 (pl) |
| HU (1) | HUE061286T2 (pl) |
| LT (1) | LT3897595T (pl) |
| MA (1) | MA54511B1 (pl) |
| PL (1) | PL3897595T3 (pl) |
| PT (1) | PT3897595T (pl) |
| RS (1) | RS64066B1 (pl) |
| SI (1) | SI3897595T1 (pl) |
| SM (1) | SMT202300093T1 (pl) |
| UA (1) | UA127874C2 (pl) |
| WO (1) | WO2020127641A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202010684YA (en) | 2018-05-10 | 2020-11-27 | Regeneron Pharma | High concentration vegf receptor fusion protein containing formulations |
| CN118767255A (zh) | 2019-06-05 | 2024-10-15 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| CN120695200A (zh) * | 2025-07-18 | 2025-09-26 | 四川省医学科学院·四川省人民医院 | 四面体框架核酸-白藜芦醇复合物在制备治疗视网膜新生血管性疾病的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3034018B1 (fr) | 2015-03-25 | 2017-11-03 | Thea Lab | Composition ophtalmique nutraceutique pour la sante oculaire |
| WO2017120601A1 (en) * | 2016-01-08 | 2017-07-13 | Clearside Biomedical, Inc. | Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics |
-
2019
- 2019-12-19 PT PT198291585T patent/PT3897595T/pt unknown
- 2019-12-19 EP EP19829158.5A patent/EP3897595B1/fr active Active
- 2019-12-19 WO PCT/EP2019/086174 patent/WO2020127641A1/fr not_active Ceased
- 2019-12-19 MA MA54511A patent/MA54511B1/fr unknown
- 2019-12-19 FI FIEP19829158.5T patent/FI3897595T3/en active
- 2019-12-19 DK DK19829158.5T patent/DK3897595T3/da active
- 2019-12-19 CA CA3122227A patent/CA3122227A1/fr active Pending
- 2019-12-19 SM SM20230093T patent/SMT202300093T1/it unknown
- 2019-12-19 UA UAA202103400A patent/UA127874C2/uk unknown
- 2019-12-19 HU HUE19829158A patent/HUE061286T2/hu unknown
- 2019-12-19 PL PL19829158.5T patent/PL3897595T3/pl unknown
- 2019-12-19 US US17/309,695 patent/US20240374634A1/en not_active Abandoned
- 2019-12-19 LT LTEPPCT/EP2019/086174T patent/LT3897595T/lt unknown
- 2019-12-19 ES ES19829158T patent/ES2940767T3/es active Active
- 2019-12-19 RS RS20230215A patent/RS64066B1/sr unknown
- 2019-12-19 HR HRP20230283TT patent/HRP20230283T1/hr unknown
- 2019-12-19 SI SI201930498T patent/SI3897595T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3897595T (lt) | 2023-04-25 |
| MA54511A (fr) | 2022-03-30 |
| HUE061286T2 (hu) | 2023-06-28 |
| PT3897595T (pt) | 2023-03-22 |
| EP3897595B1 (fr) | 2023-03-15 |
| MA54511B1 (fr) | 2023-04-28 |
| EP3897595A1 (fr) | 2021-10-27 |
| FI3897595T3 (en) | 2023-03-31 |
| UA127874C2 (uk) | 2024-01-31 |
| US20240374634A1 (en) | 2024-11-14 |
| ES2940767T3 (es) | 2023-05-11 |
| SMT202300093T1 (it) | 2023-05-12 |
| HRP20230283T1 (hr) | 2023-05-12 |
| SI3897595T1 (sl) | 2023-04-28 |
| WO2020127641A1 (fr) | 2020-06-25 |
| CA3122227A1 (fr) | 2020-06-25 |
| RS64066B1 (sr) | 2023-04-28 |
| DK3897595T3 (da) | 2023-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018008557A (es) | Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos. | |
| IL281773A (en) | Ophthalmic composition for treatment of dry eye disease | |
| LT3864003T (lt) | Integruoto streso mechanizmo provaistų moduliatoriai | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| IL268850A (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| LT3416631T (lt) | Terapiniai agentai, skirti neurodegeneracinių ligų gydymui | |
| PT3481846T (pt) | 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda | |
| CO2017000346A2 (es) | Anticuerpos de unión a protofibrillas aβ | |
| PL3897595T3 (pl) | Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną | |
| BR112016027136A2 (pt) | Válvula protética para tratamento de doenças que causam refluxo afetando os membros inferiores | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| SG11202011010YA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| SG11202011018PA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| HUE071155T2 (hu) | Biszkolin-tetratiomolibdát Wilson-kór kezelésére | |
| MA46621A (fr) | Traitements combinés comprenant l'administration d'imidazopyrazinones | |
| IL281244A (en) | Combination therapy for the treatment of liver disease | |
| IL278889A (en) | Dosing regimen for the treatment of PI3K-related disorders | |
| DK3419672T3 (da) | Genterapi til behandling af retinal degenerationssygdom | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| HUE069280T2 (hu) | Ebselen a Meniere-kór kezelésére történõ felhasználásra | |
| IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
| EP3829501C0 (en) | RETINAL IMPLANTATION DEVICE | |
| EP3801386C0 (en) | CORNEAL IMPLANT | |
| PL3515409T3 (pl) | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych | |
| DK3519050T3 (da) | Sammensætninger til behandling af oftalmiske sygdomme |